MERRIMACK PHARMACEUTICALS INC·4

Dec 13, 4:15 PM ET

Drummond Daryl C 4

4 · MERRIMACK PHARMACEUTICALS INC · Filed Dec 13, 2018

Insider Transaction Report

Form 4
Period: 2018-12-11
Drummond Daryl C
Head of Research
Transactions
  • Award

    Stock Option (right to buy)

    2018-12-11+45,00045,000 total
    Exercise: $4.15Exp: 2028-12-10Common Stock (45,000 underlying)
Footnotes (1)
  • [F1]This option vests as to 1/12th of the total number of shares granted on 3/11/19 and an additional 1/12th of the total number of shares granted at the end of each successive three month period thereafter until 12/11/21.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION